Back to Awarded Treatment Trials


Awarded Trial: 00-226

Grant ID

00-226

Illness

Schizophrenia

Primary Drug/Intervention

D-Cycloserine

Primary Dosage

60 mg

Secondary Drug Intervention

Glycine

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Kee

Sample Size

45

Duration of Study Period for Each Subject

16 weeks

Outcome Measurements

Facial emotion identification, voice emotion

Results

Nineteen subjects were enrolled into the three arms of the study: cycloserine (n=7), glycine (n=6) or placebo (n=6). There were no significant differences between groups.

Publication

N/A

Link

N/A

PI Name

Kimmy Kee

Degree

PhD

Center

Greater Los Angeles Healthcare Center

Institution

UCLA/VA

Address

11301 Wilshire Blvd (MIRECC 210A), Bldg 210

City or Town

Los Angeles

State or Province

CA

Zip or Postal Code

90073

Country

USA

Email Address

kee@ucla.edu